Aptevo Therapeutics APVO
NASDAQ APVO
$1.82 -0.04 (-2.15%)
At close: Sep 30, 2026 · 4:00 PM EDT

Aptevo Therapeutics (APVO) Accounts Payables (2015 - 2026)

Updated

Aptevo Therapeutics' Accounts Payables came in at $1.16 million for Q2 2026, down 60.0% from $2.9 million a year earlier but up 30.6% from the prior quarter.

Analysis

Aptevo Therapeutics (APVO) Accounts Payables (2015 - 2026) Analysis & Trends

At the end of FY2025, Aptevo Therapeutics' Accounts Payables was $877,000, down 29.4% from FY2024.

  • Accounts Payables carries a five-year compound annual growth rate of -30.9% (FY2020 to FY2025).
  • Going back by year, Accounts Payables was $1.24 million in FY2024 (-68.8%), $3.98 million in FY2023 (+13.9%), $3.5 million in FY2022 (+1.1%) and $3.46 million in FY2021 (-38.0%).
  • The five-year range for quarterly Accounts Payables is $877,000 (Q4 2025) to $4.87 million (Q2 2023).
  • Year-over-year, Accounts Payables has declined for five consecutive quarters, with an average decline of 38.0% over the last eight quarters.
  • The fastest year-over-year change in Accounts Payables over five years came in Q2 2023 (growth of 49.1%), and the weakest in Q1 2026 (a decline of 76.5%).
  • Business Quant data shows APVO's Accounts Payables at $890,000 (Q1 2026), $877,000 (Q4 2025) and $2.22 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 9.22 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 33.30 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 3.83 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.26 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -22.89 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 2.87 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 674.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.58 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 429.50 Mn
10 Aptevo Therapeutics 2.58 Mn -64.42 Mn - 1.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.16 Mn
Mar 31, 2026 890,000.00
Dec 31, 2025 877,000.00
Sep 30, 2025 2.22 Mn
Jun 30, 2025 2.90 Mn
Mar 31, 2025 3.79 Mn
Dec 31, 2024 1.24 Mn
Sep 30, 2024 3.53 Mn
Jun 30, 2024 3.74 Mn
Mar 31, 2024 3.72 Mn
Dec 31, 2023 3.98 Mn
Sep 30, 2023 4.00 Mn
Jun 30, 2023 4.87 Mn
Mar 31, 2023 4.13 Mn
Dec 31, 2022 3.50 Mn
Sep 30, 2022 3.24 Mn
Jun 30, 2022 3.27 Mn
Mar 31, 2022 3.91 Mn
Dec 31, 2021 3.46 Mn
Sep 30, 2021 3.69 Mn
API Access

Aptevo Therapeutics Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=APVO&period=max&api_key=YOUR_API_KEY